Bausch + Lomb, Year's Second-Biggest IPO, Pops in Public Debut | Barron's
JPM 2022: Bausch + Lomb files IPO for its eye care spinout | Fierce Biotech
Bausch & Lomb prices IPO at $18/share, below expected range (Pending:BLCO) | Seeking Alpha
Bausch Health Spin-off Notes – Stock Spinoff Investing
Bausch und lomb -Fotos und -Bildmaterial in hoher Auflösung – Alamy
Investing Club: Bausch Health drops on IPO filing. But we're buying more as our thesis starts to play out
IPO-pedia | Bau... - moomoo
Bausch + Lomb IPO: Everything you need to know about Bausch + Lomb - Optical Prism Magazine
Bausch + Lomb Seeks $840 Million in U.S. IPO of Contact-Lens Maker - Bloomberg
Bausch + Lomb IPO: What You Need to Know | Kiplinger
Bausch & Lomb climbs in debut after downsized listing | Financial Times
After IPO, Bausch + Lomb turns to an industry favorite to run the company - MarketWatch
Eye-Care Company Bausch & Lomb Files for IPO - WSJ
Bausch Health (BHC) Stock Plunges 25% After Bausch + Lomb IPO | InvestorPlace
Busted Bausch + Lomb IPO To Doom IPO Market, Cash Burning Startups
Why Bausch + Lomb IPO is worth a look | finder.com
Bausch + Lomb valued at $6.5 billion after stock ticks up in NYSE debut | Reuters
Bausch + Lomb IPO: Everything you need to know about Bausch + Lomb
Bausch + Lomb: Strong Buy After IPO Lock-Up Date (NYSE:BLCO) | Seeking Alpha
Bausch & Lomb: Enttäuschung mit Folgen - DER AKTIONÄR
Bausch + Lomb sees 5% organic sales growth in Q1 as IPO wraps up | Article | Eyewear Intelligence
BLCO Stock IPO: When Does Bausch + Lomb Go Public? What Is the Bausch + Lomb IPO Price Range? | InvestorPlace
